Skip to content Skip to navigation

Cases with temporal coverage in year 2013

Displaying 21 - 26 of 26 results

Gillette’s “Shave India Movement”: Razor Sharp against the Stubble

This case won the Inclusive Business Models category at the EFMD Case Writing Competition 2014 and commended at the Emerald and SMU Case Competition 2013.
More details here.

This is a two-part case series. Case A begins in April 2010, where Sharat Verma, the brand manager for Gillette India,...
S$6.00

GVK EMRI: Social Entrepreneurship and Innovation in Emergency Medical Response

SEMRI is the first not-for-profit public private partnership (PPP) arrangement in the healthcare sector in India. From its modest beginnings of providing emergency response services with 15 ambulances in a single city, EMRI grew its operations across 8 states to 1,550 ambulances serving 366 million...
S$6.00

Banning Telecommuting at Yahoo!

This case is set in February 2013, when several Yahoo! employees leaked a confidential memo from the human resources department concerning a telecommuting ban that is to be imposed in June that year. There are strong responses from many people, both from inside and outside Yahoo, criticising the...
S$6.00

‘Campus Connect’: An Infosys Program to Develop India’s Information Technology Ecosystem

This case is set in April 2013, and discusses the key elements that have contributed to the success of Infosys Ltd’s Campus Connect Programme (CC) in developing India’s Information Technology talent over the past eight years. The CC programme is an industry-academia initiative that re-constructs...
S$6.00

Sentosa: Asia’s Favourite Playground

This is a three-part case series on the Sentosa Leisure Group based in Singapore. The three cases focus on: Case A — marketing / analytics; Case B — IT solution design; Case (C) — long-term strategy.
In this case series, Esther Wong, deputy director of solutions technology, is tasked with boosting...
S$6.00

Novartis Loses Patent Battle In India: Time to Realign the Business Model to Emerging Markets?

On April 1, 2013, the Supreme Court of India rejects Novartis’ patent application for its cancer treatment drug, Glivec. Many share the opinion that Indians should have access to cheaper generic alternatives for life-saving drugs and that multinational pharmaceutical companies should not be allowed...
S$6.00

Pages

Looking for something?